The Leukemia and Lymphoma Society   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: New York NY United States (1949)

Organization Overview

First Clinical Trial
2003
NCT00068302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

The Leukemia and Lymphoma Society